H. Lundbeck A/S

10/20/2025 | Press release | Distributed by Public on 10/20/2025 01:20

Lundbeck and Contera Pharma announce research collaboration to advance RNA-targeting medicines for serious neurological conditions

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
H. Lundbeck A/S published this content on October 20, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 20, 2025 at 07:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]